|
Basic and Clinical Neuroscience، جلد ۱۶، شماره ۴، صفحات ۰-۰
|
|
|
عنوان فارسی |
|
|
چکیده فارسی مقاله |
|
|
کلیدواژههای فارسی مقاله |
|
|
عنوان انگلیسی |
The Modulatory Effects of CB1 Receptors on Social Behavior and Anxiety in Rats: Insights from an Empathic Pain Paradigm |
|
چکیده انگلیسی مقاله |
Objectives: Cannabinoid receptor type 1 (CB1) is extensively distributed across brain regions that are crucial for emotional processing, social cognition, and anxiety, including the prefrontal cortex, amygdala, and hippocampus. Dysregulation of CB1 receptors (CB1Rs) has been associated with several disorders characterized by impaired empathy, social behavior, and anxiety. This study aimed to investigate the modulatory role of CB1Rs in social interaction and anxiety in an empathic pain model in rats. Methods: Forty-eight adults male Wistar rats were used (n = 8 for each group). One sibling received formalin injection into the hind paw five times within a nine-day period (Demonstrator), and the other siblings reported pain (Observer) while being treated with DMSO, the cannabinoid type 1 receptor (CB1R) agonist WIN 55,212–2 (WIN; 3 mg/kg, i.p.), or the CB1R antagonist rimonabant (1 mg/kg, i.p.). Treatments were administered intraperitoneally 30 minutes prior to behavioral tests conducted on day 10, which were used to assess social behavior and anxiety. Results: The findings indicate that empathic pain can impair social behavior and elicit anxiety-like effects. Rimonabant was effective in ameliorating deficits induced by empathic pain; conversely, WIN did not have a significant effect. Conclusion: These results suggest that CB1Rs play a modulatory role in social contagion. This modulation may provide new therapeutic targets for conditions such as autism spectrum disorder, schizophrenia, and other psychological disorders characterized by impaired empathy and dysregulated social behavior associated with the CB1 signaling pathway. |
|
کلیدواژههای انگلیسی مقاله |
Cannabinoid system, Anxiety, Empathic pain, Social behavior, Rimonabant, WIN 55,212–2 |
|
نویسندگان مقاله |
| Fatemeh Rahimi Shourmasti Student Research Committee, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
| Raheleh Rafaiee Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
| Seyedeh Masoumeh Seyedhosseini Tamijani Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
| Mehdi Khodamoradi Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
| Mohammad Shabani Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
| Hamed Ghazvini Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
|
|
نشانی اینترنتی |
http://bcn.iums.ac.ir/browse.php?a_code=A-10-2297-2&slc_lang=en&sid=1 |
فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
کد مقاله (doi) |
|
زبان مقاله منتشر شده |
en |
موضوعات مقاله منتشر شده |
Behavioral Neuroscience |
نوع مقاله منتشر شده |
Original |
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|